ABEV analyst estimates
Ambev (ABEV) analyst ratings, the average price target and its range, and every firm's latest call.
ABEV analyst ratings and price targets
| Date | Firm | Call | Target |
|---|---|---|---|
| Aug 11, 2026 | UBS | Ambev price target lowered to $2.85 from $2.90 at UBS | $2.85 |
| May 14, 2026 | UBS | Ambev price target raised to $2.90 from $2.65 at UBS | $2.90 |
| May 6, 2026 | Barclays | Ambev price target raised to $3.50 from $3 at Barclays | $3.50 |
| Apr 16, 2026 | UBS | Ambev downgraded to Sell from Neutral at UBS | $2.65 |
| Feb 17, 2026 | Barclays | Ambev price target raised to $3 from $2.50 at Barclays | $3.00 |
| Nov 26, 2025 | Bernstein | Ambev downgraded to Market Perform from Outperform at Bernstein | $2.88 |
| Jan 8, 2025 | Bernstein | Ambev price target lowered to $2.57 from $3.08 at Bernstein | $2.57 |
| Jul 11, 2024 | Goldman Sachs | Ambev price target lowered to $2.10 from $2.25 at Goldman Sachs | $2.10 |
- 0 firms rate ABEV: 0 buy, 0 hold, 0 sell.
- The average price target is $3.17 from 2 analysts, from $2.85 to $3.50.
Updated 2026-11-03 00:00 UTC